Related Experiment Videos
High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two
Nazanine Bayani1, Michel Rugina, Laurence Haddad-Vergnes
1Hematology Laboratory, Créteil Intercommunal Hospital Center, France. nazanine.bayani@chicreteil.fr
Abstract:
We report a 79-year-old man with two simultaneous malignant tumors (buccal epidermoid carcinoma and prostatic adenocarcinoma) who developed a severe bleeding complication at the site of the buccal tumor as well as a massive cerebral hematoma after a skull trauma. Laboratory findings showed the presence of a high-titer specific factor V inhibitor. The patient failed to respond to intravenous immunoglobulins, but both clinical and laboratory improvement was obtained after treatment with corticosteroids and cyclophosphamide.
Related Concept Videos
Tumor Immunotherapy
Treatment Resistant Cancers
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...